Author

J. Niessl

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 5 Organism:human· 5 Approach:experimental assay· 4 Research Focus:clustering· 3 Assay:flow cytometry· 3 Research Focus:host-pathogen & immune response· 3 Assay:bulk RNA-seq· 2 Research Focus:differential expression· 2

Frequent Co-Authors

C. Tremblay· 5 shared D. E. Kaufmann· 5 shared N. Brassard· 5 shared A. Finzi· 4 shared C. Morrisseau· 4 shared L. Gokool· 4 shared M. Dube· 4 shared M. Nayrac· 4 shared

Activity by Year

2021-2022 · peak 3/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

5 shared papersImmunology

C. Tremblay

Mutual co-authors in cluster

Author profile →

5 papers

Recent·Most cited

ImmunologybioRxivSep 5, 2022

A third SARS-CoV-2 mRNA vaccine dose in people receiving hemodialysis overcomes B cell defects but elicits a skewed CD4+ T cell profile

G. Sannier, A. Nicolas, M. Dube…·D. E. Kaufmann

DOI 10.1016/j.xcrm.2023.100955

humanbulk RNA-seq

𝕏 PostBluesky

ImmunologybioRxivPreprintAug 3, 2022

A long interval between priming and boosting SARS-CoV-2 mRNA vaccine doses enhances B cell responses with limited impact on T cell immunity

A. Nicolas, G. Sannier, M. Dube…·D. E. Kaufmann

This study shows that a longer interval between SARS-CoV-2 mRNA vaccine doses enhances B cell responses but has minimal impact on T cell immunity.

DOI 10.1101/2022.08.03.502672

humanflow cytometry

𝕏 PostBluesky

ImmunologybioRxivDec 18, 2021

Temporal associations of B and T cell immunity with robust vaccine responsiveness in a 16-week interval BNT162b2 regimen

M. Nayrac, M. Dube, G. Sannier…·D. E. Kaufmann

The paper examines B and T cell immunity responses to a 16-week interval BNT162b2 vaccine regimen, finding robust immune memory and functional associations between immune components.

DOI 10.1016/j.celrep.2022.111013

humanbulk RNA-seq

𝕏 PostBluesky

ImmunologybioRxivSep 23, 2021

Immune checkpoint expression on HIV-specific CD4+ T cells and response to their blockade are dependent on lineage and function

E. Brunet-Ratnasingham, A. Morou, M. Dube…·D. E. Kaufmann

DOI 10.1016/j.ebiom.2022.104254

humanflow cytometry

𝕏 PostBluesky

ImmunologybioRxivPreprintMar 18, 2021

A single BNT162b2 mRNA dose elicits antibodies with Fc-mediated effector functions and boost pre-existing humoral and T cell responses

A. Tauzin, M. Nayrac, M. Benlarbi…·A. Finzi

This study shows a single dose of the BNT162b2 mRNA vaccine elicits strong antibody and T cell responses, including Fc-mediated effector functions, and boosts pre-existing immunity in previously infected individuals.

DOI 10.1101/2021.03.18.435972

humanproteomics

𝕏 PostBluesky